Creatine Monohydrate: What It Is, What It Does, and What the Latest Research Says About the Brain

Creatine is an organic, non protein amino acid that is primarily produced by the liver, with smaller amounts also synthesised in the kidneys and pancreas. In skeletal muscle, creatine is stored with phosphate as phosphocreatine (PCr). Phosphocreatine donates its phosphate group during the conversion of adenosine diphosphate (ADP) to adenosine triphosphate (ATP), a process known as phosphorylation.

ATP is an energy carrying molecule present in the cells of all living organisms. It captures chemical energy derived from the breakdown of food and releases this energy to support cellular processes. ATP is required for three primary functions: driving metabolic reactions that do not occur spontaneously, transporting substances across cellular membranes, and enabling mechanical work such as muscle contraction.

Carbohydrate, protein, and fat are utilised by the body’s energy systems to produce ATP. The aerobic energy system can utilise carbohydrate, fat, and protein through oxidative phosphorylation and produces the greatest total yield of ATP. However, it is also the slowest energy system. The lactic acid system relies on glucose through glycolysis and predominantly fuels high intensity activity lasting several minutes. The phosphocreatine system supports very high intensity efforts lasting up to approximately 30 seconds and relies on phosphate derived from creatine phosphate.

Creatine monohydrate is one of the most extensively researched nutritional supplements and has consistently been shown to be safe, effective, and well tolerated. Following creatine loading, performance during high intensity and repeated bouts of exercise typically increases by approximately 10 to 20 percent, depending on the magnitude of the increase in muscle phosphocreatine stores.

A substantial body of research demonstrates that creatine supplementation can enhance acute exercise capacity, increase muscle mass, reduce muscle acidosis, increase the rate of phosphocreatine resynthesis, regulate aspects of cellular metabolism, act as an antioxidant, reduce injury risk, improve recovery, enhance heat tolerance, support injury rehabilitation, and provide neuroprotective effects within the brain and spinal cord. These effects underpin its usefulness across activities such as weightlifting, powerlifting, sprinting, cycling, and many team sports.

Dosing

Creatine monohydrate can be supplemented using either a rapid or a gradual dosing protocol, depending on how quickly the desired effects are needed. A rapid loading protocol typically involves consuming 5 g, or approximately 0.3 g per kilogram of body weight, four times per day. Peak muscle saturation is generally achieved within five to seven days, after which intake is reduced to approximately 5 g per day. Alternatively, creatine monohydrate can be taken at a dose of 3 to 5 g per day for approximately 28 days, resulting in a more gradual increase in muscle creatine stores.

To maintain full saturation of muscular phosphocreatine, daily intake of 3 to 5 g of creatine monohydrate is recommended, in addition to approximately 3 g obtained from dietary sources.

It is worth noting that the brain may need a different approach to the muscle, and we will come back to this point in the cognition section below.

Responders and non responders

Although creatine monohydrate is effective for most individuals, there is considerable inter individual variability in response. Some individuals experience minimal increases in muscle creatine and phosphocreatine following supplementation and are often described as non responders. In this context, non response refers to a limited physiological increase in intramuscular creatine rather than a lack of benefit or adherence.

Higher baseline muscle creatine concentrations appear to reduce the magnitude of response to supplementation. This is more commonly observed in individuals who regularly consume creatine rich foods such as red meat and seafood, or in those with greater existing muscle mass. In contrast, individuals with lower baseline creatine levels, including vegetarians, older adults, and those new to resistance training, typically demonstrate larger increases in muscle creatine content.

Importantly, responsiveness exists along a continuum. Many individuals who experience smaller increases in muscle creatine may still derive benefits over time, particularly when supplementation is combined with appropriate resistance or high intensity training. A lack of noticeable short term performance change does not indicate harm and reflects normal biological variability.

Creatine and the brain

Creatine has long been of interest beyond muscle because the brain is an energy hungry organ. It consumes roughly a fifth of the body’s resting energy, and cognitive effort increases the demand for ATP in active brain regions. Several states relevant to healthy ageing, including sleep loss, low oxygen availability, sustained mental fatigue, and ageing itself, are associated with reduced cerebral energy availability. The theory is that topping up the brain’s phosphocreatine buffer might help it cope when energy supply is stretched. This is a plausible idea with good biochemical grounding, but the human evidence is more nuanced than the popular conversation suggests, so it is worth walking through carefully.

Brain creatine uptake is slower and smaller than muscle uptake

This is one of the most important points to understand, and it has only become clear in recent years through magnetic resonance spectroscopy (MRS), a technique that measures creatine concentrations inside living tissue. Studies using MRS consistently show that a standard dose of 3 to 5 g per day raises brain total creatine by around 5 to 10 percent, which is roughly half the 15 to 20 percent rise typically seen in skeletal muscle. The brain has fewer creatine transporters at the blood brain barrier than muscle does, and it also makes some of its own creatine, which makes it more resistant to dietary loading.

The practical implication, argued in recent narrative reviews led by Candow and colleagues, is that the brain may need a higher dose than the muscle to shift its creatine stores meaningfully. This is an emerging position based largely on mechanistic and imaging evidence rather than on a body of large clinical trials, so it should be held as a reasonable working hypothesis rather than settled fact.

Cognition in healthy, well rested adults

Here the evidence has actually narrowed rather than strengthened in the last few years, which is the opposite of the impression you might get from social media.

Two well designed randomised controlled trials published in 2023 found essentially no effect of creatine on cognition in healthy adults. The larger of the two, by Sandkühler and colleagues, was a preregistered, double blind, placebo controlled crossover trial of 123 adults, roughly half of whom were vegetarian. Six weeks of 5 g per day produced no significant improvement in reasoning or working memory, and the statistical analysis gave strong evidence against any large effect. Notably, the vegetarians in this trial did not benefit more than the omnivores, which directly challenges an assumption that is widely repeated in the popular literature. A second 2023 trial by Moriarty and colleagues tested both 10 g and 20 g per day for six weeks in young adults and again found no effect on processing speed, memory, or attention.

The picture from systematic reviews is mixed and somewhat contested. A 2023 meta analysis by Prokopidis and colleagues reported memory improvements, with the largest effects in older adults, and a 2024 meta analysis by Xu and colleagues reported a small positive effect on memory. However, both have been criticised, including by the European Food Safety Authority in its 2024 assessment, for a statistical error that pooled non independent outcomes from the same trials and inflated the apparent evidence. After accounting for this, the overall signal in healthy adults largely disappears, with the exception of the older adult subgroup, which is discussed below. A separate 2024 review by McMorris and colleagues concluded that the existing literature does not support an effect on cognition in unstressed healthy adults, with signals appearing only under stressors.

The honest summary for a healthy, well rested, well fed midlife adult is that you should not expect a noticeable cognitive boost from creatine. The strongest evidence sits elsewhere.

Cognition under stress: where the signal is more convincing

Creatine looks more promising when the brain is under pressure, which makes sense given its role as an energy buffer.

The standout recent study, by Gordji-Nejad and colleagues in 2024, gave 15 sleep deprived adults a single very large dose of around 0.35 g per kilogram of body weight, which is roughly 25 g for a 70 kg person. Using brain imaging, the researchers showed that this single dose raised brain creatine and energy markers within a few hours and reduced the decline in processing speed and working memory caused by sleep deprivation, with effects lasting up to nine hours. This was the first clear demonstration that brain creatine can shift acutely with a single oral dose, overturning the older assumption that it always takes weeks. A 2025 follow up by the same group reproduced the cognitive benefit at a lower dose of 0.2 g per kilogram.

This fits with earlier work. Studies in the 2000s found that creatine improved mood and reaction time during 24 hours of sleep deprivation, and a 2015 study showed that creatine helped preserve attention under acute low oxygen conditions. A 2020 crossover trial found that creatine improved accuracy on a demanding attention task during prolonged mental fatigue, although it did not help on every measure.

The takeaway is that creatine’s cognitive benefits, where they exist, appear most reliably when the brain’s energy supply is challenged, such as by poor sleep, high mental load, or low oxygen, rather than under ordinary rested conditions.

Older adults

Older adults are a particularly relevant group for healthy ageing, and they are also the group where the cognition signal is most durable. The older adult subgroup in the Prokopidis meta analysis survived the statistical re-analysis better than the healthy young adult data did, and recent narrative reviews continue to support a moderate benefit for memory and processing speed in this population. Brain creatine declines with age, and baseline stores are lower, which is consistent with the broader pattern that the people most likely to benefit are those who start with less. The evidence here is suggestive rather than definitive, but it is more encouraging than the data in younger people.

Alzheimer’s disease and mild cognitive impairment

This is the area where claims most often run ahead of the evidence, so it deserves careful framing.

The first ever human trial of creatine in Alzheimer’s disease was published in 2025 by Smith and colleagues. It gave 20 g per day for eight weeks to 20 people with mild to moderate Alzheimer’s disease. The results were encouraging on the surface. Brain creatine rose by 11 percent, adherence was high, the supplement was well tolerated, and several measures of cognition improved, including working memory and fluid cognition. However, and this is the critical caveat, the trial had no placebo group. It was a single arm feasibility study, which means the cognitive improvements could partly reflect practice effects from repeating the tests, expectancy, or normal variation rather than a true drug effect. The authors themselves were explicit that the results only provide preliminary support for the hypothesis and that a proper randomised controlled trial is needed before any conclusions can be drawn.

Beyond this one small trial, the human evidence in dementia and related conditions is thin and inconsistent. Trials in Huntington’s disease, Parkinson’s disease, and motor neurone disease have been largely negative for their main outcomes, though a Parkinson’s trial reported a reduction in depressive symptoms as a secondary finding. Animal models of Alzheimer’s disease show reductions in pathology and improvements in memory, but animal evidence does not reliably translate to humans.

The defensible position is this. Creatine is biologically plausible as a brain energy support, it is safe, and there is a single small and uncontrolled human signal in established Alzheimer’s disease. There is no evidence at present that creatine prevents dementia or slows its onset, and the preventive trials simply have not been done. Anyone claiming that creatine prevents dementia is overstating what we know.

Mood and depression

There is a small and reasonably consistent signal that creatine may help with depressive symptoms, particularly as an add on to standard antidepressant treatment, and particularly in women. A 2025 systematic review and meta analysis pooling 11 trials and around 1,093 people found a small to moderate benefit, but the certainty of the evidence was rated very low, the effect was not clinically important on average, and there were signs of possible bias favouring creatine. Earlier trials suggested that higher doses of around 10 g per day produced the largest changes in frontal brain energy markers. This is an area to watch rather than a reason to take creatine for mood at this stage.

Women, menopause, and vegetarians

Women have endogenous creatine stores that are estimated to be substantially lower than men’s, consume less dietary creatine on average, and experience hormonal influences on the creatine system, which has led researchers such as Smith-Ryan and colleagues to argue that women may be an under recognised group of responders. Perimenopause and menopause have been proposed as phases of elevated need. This is a reasonable hypothesis, but direct cognitive trials in menopausal women are scarce, so the case rests more on biological rationale than on outcome data at this point.

On vegetarians, the popular claim that they gain a larger cognitive benefit from creatine is weaker than it is often presented. An early small study did find a memory advantage in vegetarians, but the much larger 2023 Sandkühler trial, which included a substantial vegetarian group, found no greater cognitive benefit in vegetarians than in omnivores. Vegetarians do tend to have lower muscle creatine and may respond more for physical performance, but the cognitive case specifically is not well supported.

Clinical and health related applications beyond the brain

Creatine monohydrate has also been studied across a range of other clinical and health related contexts, including genetic creatine deficiencies, ageing related muscle loss, stroke, ischaemic heart disease, and pregnancy. The most robust of these for the healthy ageing population is the combination of creatine with resistance training in older adults. A pooled analysis of 22 trials in adults with an average age in the late 50s to 70s found that creatine added to resistance training increased lean tissue mass and improved both upper and lower body strength compared with training alone. For a midlife and older audience concerned with preserving muscle, bone, and the ability to move well and avoid falls, this is arguably the best supported reason to take creatine.

While it remains unclear whether creatine supplementation can alter the progression of neurodegenerative disease, its involvement in cellular energy metabolism and associated neuroprotective mechanisms continues to drive research interest in its broader physiological applications.

Safety

Creatine monohydrate has a strong safety profile and is generally considered safe for use in healthy adults when consumed at recommended doses. It may be introduced at any stage of training and does not require a prolonged exercise history prior to supplementation. In older adults, creatine supplementation has been shown to be safe and may be particularly relevant given age related declines in muscle mass, strength, and phosphocreatine availability.

Although creatine has been used safely in younger populations within research settings, supplementation in adolescents should be approached cautiously and ideally under professional guidance. Individuals with pre existing kidney disease or other significant medical conditions should seek medical advice prior to commencing supplementation, despite the absence of evidence indicating harm in healthy populations.

Concerns have previously been raised regarding potential adverse effects of creatine on renal health. Isolated case reports suggested an association between creatine use and renal dysfunction in athletes. However, these studies were unable to establish causality, and a substantial body of subsequent research has demonstrated that creatine supplementation does not impair renal function in healthy individuals. This has been confirmed by meta analyses published in 2019 and 2025, which found that creatine raises serum creatinine slightly without altering the underlying measures of kidney function. This point matters in practice. Because creatine converts to creatinine, supplementation will inflate serum creatinine and any kidney function estimate based on it. This is an expected biochemical artefact, not kidney damage. It is worth telling your doctor that you take creatine before a blood test, because an elevated creatinine reading can otherwise be misinterpreted.

From a long term perspective, muscle creatine concentrations do not fall below baseline levels following cessation of supplementation. This indicates that endogenous creatine synthesis is not suppressed with continued use and that creatine monohydrate may be taken on an ongoing basis if desired.

Practical guidance for midlife adults

Bringing the evidence together, here is a defensible approach for someone in midlife focused on healthy ageing.

A daily dose of 5 g of creatine monohydrate, taken indefinitely, has the strongest safety evidence, saturates the muscle, and modestly raises brain creatine. A loading phase is optional and simply speeds up muscle saturation. If your primary goal is the brain rather than the muscle, a higher dose of around 10 g per day has mechanistic support, particularly for older adults, vegetarians and vegans, postmenopausal women, and those experiencing poor sleep or high cognitive load. It is worth being clear that the higher dose for cognition rests on imaging and reasoning rather than on a body of large trials, so it is a sensible option rather than a proven prescription.

Take creatine with a meal and stay well hydrated. Timing through the day is not critical. Pair it with resistance training to get the best supported healthy ageing benefits for muscle, bone, and function. Choose creatine monohydrate rather than the newer and more expensive forms, which offer no proven advantage. And do not expect a cognitive lift if you are already well rested and well fed, because that is not where the evidence points.

In summary, creatine monohydrate is a well tolerated and extensively studied supplement with demonstrated benefits for high intensity exercise performance, muscle mass, and recovery, and a particularly strong case when combined with resistance training in older adults. Its effects on cognition are real but conditional, appearing most reliably when the brain is under energy stress, in older adults, and possibly in those with low baseline stores, while remaining unproven in well rested healthy people. Its potential role in dementia is biologically plausible and supported by a single small and uncontrolled human trial, but it is not yet established and should not be claimed as proven. When used at evidence based doses, creatine monohydrate represents a low risk intervention with benefits that extend well beyond sport.

References

Antonio J, Candow DG, Forbes SC, et al. Common questions and misconceptions about creatine supplementation: what does the scientific evidence really show? J Int Soc Sports Nutr. 2021;18(1):13.

Antonio J, Brown AF, Candow DG, et al. Part II. Common questions and misconceptions about creatine supplementation: what does the scientific evidence really show? J Int Soc Sports Nutr. 2025;22(1):2441760.

Antonio J, Candow DG, Forbes SC, et al. Creatine supplementation: a brief review of adverse events. J Int Soc Sports Nutr. 2025;22(1):2488937.

Avgerinos KI, Spyrou N, Bougioukas KI, Kapogiannis D. Effects of creatine supplementation on cognitive function of healthy individuals: a systematic review of randomized controlled trials. Exp Gerontol. 2018;108:166–173.

Benton D, Donohoe R. The influence of creatine supplementation on the cognitive functioning of vegetarians and omnivores. Br J Nutr. 2011;105(7):1100–1105.

Candow DG, Forbes SC, Ostojic SM, et al. “Heads Up” for creatine supplementation and its potential applications for brain health and function. Sports Med. 2023;53(Suppl 1):49–65.

Candow DG, Forbes SC, et al. Creatine supplementation: more is likely better for brain bioenergetics, health and function. J Psychiatry Brain Sci. 2025;10(4):e250006. doi:10.20900/jpbs.20250006.

Chilibeck PD, Kaviani M, Candow DG, Zello GA. Effect of creatine supplementation during resistance training on lean tissue mass and muscular strength in older adults: a meta-analysis. Open Access J Sports Med. 2017;8:213–226.

de Souza e Silva A, Pertille A, Reis Barbosa CG, et al. Effects of creatine supplementation on renal function: a systematic review and meta-analysis. J Ren Nutr. 2019;29(6):480–489.

Dolan E, Gualano B, Rawson ES. Beyond muscle: the effects of creatine supplementation on brain creatine, cognitive processing and traumatic brain injury. Eur J Sport Sci. 2019;19(1):1–14.

Eckert T, Pascher J. Letter to the editor regarding the meta-analysis on creatine and memory. Nutr Rev. 2023;81(11):1495–1496.

Eckert T, Lima JPS, Dariva LF, et al. Creatine supplementation for treating symptoms of depression: a systematic review and meta-analysis. Br J Nutr. Published online November 2025. doi:10.1017/S0007114525105588.

European Food Safety Authority (EFSA) Panel on Nutrition, Novel Foods and Food Allergens. Creatine and improvement in cognitive function: evaluation of a health claim. EFSA Journal. 2024;22(11):e9100.

Forbes SC, Cordingley DM, Cornish SM, et al. Effects of creatine supplementation on brain function and health. Nutrients. 2022;14(5):921.

Gordji-Nejad A, Matusch A, Kleedörfer S, et al. Single dose creatine improves cognitive performance and induces changes in cerebral high energy phosphates during sleep deprivation. Sci Rep. 2024;14:4937.

Gordji-Nejad A, et al. Reduced dose creatine and cognitive performance during sleep deprivation. Nutrients. 2025;17(8):1192.

Harris RC, Soderlund K, Hultman E. Elevation of creatine in resting and exercised muscle of normal subjects by creatine supplementation. Clin Sci (Lond). 1992;83(3):367–374.

Hultman E, Soderlund K, Timmons JA, et al. Muscle creatine loading in men. J Appl Physiol (1985). 1996;81(1):232–237.

Kieburtz K, Tilley BC, Elm JJ, et al. (NINDS Exploratory Trials in Parkinson Disease, NET-PD, Investigators). Effect of creatine monohydrate on clinical progression in patients with Parkinson disease: a randomized clinical trial. JAMA. 2015;313(6):584–593.

Kondo DG, Forrest LN, Shi X, et al. Creatine target engagement with brain bioenergetics: a dose-ranging phosphorus-31 magnetic resonance spectroscopy study of adolescent females with SSRI-resistant depression. Amino Acids. 2016;48(8):1941–1954.

Kreider RB. Effects of creatine supplementation on performance and training adaptations. Mol Cell Biochem. 2003;244(1–2):89–94.

Kreider RB, Kalman DS, Antonio J, et al. International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine. J Int Soc Sports Nutr. 2017;14:18. doi:10.1186/s12970-017-0173-z.

McMorris T, Harris RC, Swain J, et al. Effect of creatine supplementation and sleep deprivation, with mild exercise, on cognitive and psychomotor performance, mood state, and plasma concentrations of catecholamines and cortisol. Psychopharmacology (Berl). 2006;185(1):93–103.

McMorris T, Harris RC, Howard AN, et al. Creatine supplementation, sleep deprivation, cortisol, melatonin and behavior. Physiol Behav. 2007;90(1):21–28.

McMorris T, et al. A critical review of the evidence for creatine supplementation and cognition. Behav Brain Res. 2024;466:114982.

Moriarty T, et al. Dose–response of creatine supplementation on cognitive function in healthy young adults. Brain Sci. 2023;13(9):1276.

Naeini F, et al. Effect of creatine supplementation on kidney function: a systematic review and meta-analysis. BMC Nephrol. 2025;26:622.

Pritchard NR, Kalra PA. Renal dysfunction accompanying oral creatine supplements. Lancet. 1998;351(9111):1252–1253.

Prokopidis K, Giannos P, Triantafyllidis KK, et al. Effects of creatine supplementation on memory in healthy individuals: a systematic review and meta-analysis of randomized controlled trials. Nutr Rev. 2023;81(4):416–427.

Rosas HD, Doros G, Gevorkian S, et al. PRECREST: a phase II prevention and biomarker trial of creatine in at-risk Huntington disease. Neurology. 2014;82(10):850–857.

Sandkühler JF, Kersting X, Faust A, et al. The effects of creatine supplementation on cognitive performance—a randomised controlled study. BMC Med. 2023;21:440.

Smith-Ryan AE, Cabre HE, Eckerson JM, Candow DG. Creatine supplementation in women’s health: a lifespan perspective. Nutrients. 2021;13(3):877. doi:10.3390/nu13030877.

Smith RN, Agharkar AS, Gonzales EB. A review of creatine supplementation in age-related diseases: more than a supplement for athletes. F1000Res. 2014;3:222. doi:10.12688/f1000research.5218.1.

Smith AN, et al. Creatine as a therapeutic target in Alzheimer’s disease. Curr Dev Nutr. 2023;7(11):102011.

Smith AN, Choi IY, Lee P, et al. Creatine monohydrate pilot in Alzheimer’s: feasibility, brain creatine, and cognition. Alzheimers Dement (N Y). 2025;11(2):e70101. doi:10.1002/trc2.70101.

Solis MY, Artioli GG, Otaduy MCG, et al. Effect of age, diet, and tissue type on PCr response to creatine supplementation. J Appl Physiol (1985). 2017;123(2):407–414.

Thorsteinsdottir B, Grande JP, Garovic VD. Acute renal failure in a young weight lifter taking multiple food supplements, including creatine monohydrate. J Ren Nutr. 2006;16(4):341–345.

Turner CE, Byblow WD, Gant N. Creatine supplementation enhances corticomotor excitability and cognitive performance during oxygen deprivation. J Neurosci. 2015;35(4):1773–1780.

Van Cutsem J, Roelands B, Pluym B, et al. Can creatine combat the mental fatigue–associated decrease in visuomotor skills? Med Sci Sports Exerc. 2020;52(1):120–130. doi:10.1249/MSS.0000000000002122.

Xu C, et al. The effects of creatine supplementation on cognitive function in adults: a systematic review and meta-analysis. Front Nutr. 2024;11:1424972.